Irena Cervena

Title: Irena Cervena: Innovator in Neuropharmacology

Introduction

Irena Cervena is a prominent inventor based in Prague, Czech Republic. She has made significant contributions to the field of neuropharmacology, particularly in the development of compounds for the treatment of schizophrenia. With a total of 2 patents, her work has garnered attention for its potential therapeutic applications.

Latest Patents

Cervena's latest patents include innovative compounds such as N-substituted 2-chloro-7-fluoro-10-piperazino-10,11-dihydrodibenzo (B,F) and polysubstituted derivatives of 10-piperazinodibenzo (b,f) thiepine. These compounds are characterized by their potent antidopaminergic properties and are designed to be non-cataleptic neuroleptics. They are expected to be substantially free of the usual undesired extrapyramidal side effects, making them promising candidates for pharmacological evaluation and therapeutic application.

Career Highlights

Throughout her career, Irena Cervena has worked with several notable companies in the pharmaceutical industry. She has been associated with Spofa, a well-known pharmaceutical manufacturer, as well as Spojene Podniky Pro Zdravotnickou Vyrobu and Spofa United Pharmaceutical Works. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Cervena has collaborated with esteemed colleagues such as Miroslav Protiva and Jiri Jilek. These partnerships have facilitated the advancement of her research and the successful development of her patented compounds.

Conclusion

Irena Cervena's contributions to neuropharmacology through her innovative patents highlight her role as a significant inventor in the field. Her work continues to pave the way for advancements in the treatment of schizophrenia and other related conditions.